132-Dioxathiolane 22-Dioxide - China Factory, Suppliers, Manufacturers

132-Dioxathiolane 22-Dioxide, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Ethylene Sulfate (DTD) CAS 1072-53-3 Purity >98.0% (GC) Factory Electrolyte Additive
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Method Of Analyzing Palladium Content In Palladium Catalysts

1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) ...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...

2022.12.24 05:04:56
2022.12.10 10:28:25
2022.09.05 07:10:32
2022.08.31 18:21:18
2022.08.23 00:10:02
2022.01.20 08:54:17

132-Dioxathiolane 22-Dioxide - China Factory, Suppliers, Manufacturers

Related Products

Ethylene Sulfate (DTD) CAS 1072-53-3 Purity >98.0% (GC) Factory Electrolyte Additive

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

1,3:2,4-Dibenzylidene Sorbitol CAS 32647-67-9 Purity >98.0%

1-Boc-2-Methylpiperazine CAS 120737-78-2 Purity >98.0% (GC)

3-Thiopheneethanol CAS 13781-67-4 Purity >99.0% (GC) Factory Main Product

3-Aminoindazole CAS 874-05-5 Purity >98.0% (HPLC)

H-Leu-OtBu·HCl CAS 2748-02-9 L-Leucine tert-Butyl Ester HCl Purity >98.0% (HPLC)

Cyanamide 50% in H2O CAS 420-04-2 Factory High Quality

Tris(Trimethylsilyl)Phosphate (TMSP) CAS 10497-05-9 Purity >99.0% (GC) Factory

3-Cyanophenylboronic Acid CAS 150255-96-2 Purity >98.5% (HPLC) High Quality

1-Imidazoleacetic Acid CAS 22884-10-2 Purity ≥99.0% (GC) Factory Zoledronic Acid Intermediate

4-Chlorotoluene CAS 106-43-4 Purity >99.0% (GC)

Rapamycin Sirolimus RAPA CAS 53123-88-9 Assay ≥98.5% API Factory High Purity

4-Aminopyrazolo[3,4-d]pyrimidine CAS 2380-63-4 Ibrutinib Intermediate Purity >98.0% (HPLC)

The “Summit on COVID-19 Diagnostics & Treatment”

Xi presents award to top scientists

Method Of Analyzing Palladium Content In Palladium Catalysts

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

New COVID treatments offer hope

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

2022.12.24 05:04:56

2022.12.10 10:28:25

2022.09.05 07:10:32

2022.08.31 18:21:18

2022.08.23 00:10:02

2022.01.20 08:54:17

related search